AMGEN
The computed 12-month bankruptcy probability of AMGEN is 0.4% (very low). The 2023 annual accounts show equity of €7.73M and a net result of €4.47M. Equity is shrinking by ~13.3% per year across the filed fiscal years. The company has been active since 1989 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €7.73M |
| Net result | €4.47M |
| Staff (FTE) | 100.3 |
| Active | 36 yrs |
Strong profile, led by stability.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Fiscal year | 2023 |
|---|---|
| Deposit | volledig |
| Revenue | €147.15M |
| EBITDA | €6.16M |
| Net profit | €4.47M |
| Cash flow | €4.66M |
| Staff costs | €18.25M |
| Income taxes | €2.04M |
| Dividends | €5.00M |
| Total assets | €41.22M |
| Equity | €7.73M |
| Debt | €33.49M |
| of which ≤ 1y | €30.58M |
| of which > 1y | - |
| Working capital | €9.84M |
| Employees (FTE) | 100.3 |
| 2023 | |
|---|---|
| Current ratio | 1.32 |
| Quick ratio | 1.32 |
| Working capital ratio | 23.9% |
| Solvency | 18.7% |
| Debt / equity | 4.33 |
| Long-term debt ratio | - |
| Interest coverage | 52.34 |
| Gross margin | 32.4% |
| Net margin | 3.0% |
| ROA | 10.8% |
| ROE | 57.8% |
| EBITDA margin | 4.2% |
| Days sales outstanding | 76d |
| Days payable outstanding | 99d |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2023 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €41.22M |
| Fixed assets | 21/28 | €794k |
| Tangible fixed assets | 22/27 | €794k |
| Current assets | 29/58 | €40.42M |
| Amounts receivable within one year | 40/41 | €40.40M |
| Cash & bank | 54/58 | €2k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €41.22M |
| Equity | 10/15 | €7.73M |
| Contributions / capital | 10/11 | €174k |
| Reserves | 13 | €17k |
| Accumulated profits (losses) | 14 | €7.54M |
| Provisions & deferred taxes | 16 | €4k |
| Amounts payable | 17/49 | €33.49M |
| Amounts payable within one year | 42/48 | €30.58M |
| Trade debts payable within one year | 44 | €26.87M |
| Income statement | ||
| Turnover | 70 | €147.15M |
| Operating result | 9901 | €5.96M |
| Financial income | 75 | €665k |
| Financial charges | 65 | €118k |
| Result before taxes | 9903 | €6.51M |
| Income taxes | 67/77 | €2.04M |
| Net result for the period | 9904 | €4.47M |
| Result to be appropriated | 9905 | €4.47M |
-
Current07-11-2024 → present
-
Current07-11-2024 → present
-
Current05-09-2024 → present
-
Current01-04-2023 → present
Historic, not recently confirmed (3)
-
Not recently confirmedlast confirmed in an act from 2018
-
Not recently confirmedlast confirmed in an act from 2017
2 events
- 01-02-2017 Mandate renewed· Director
- 06-11-2013 Appointed· Director
-
Not recently confirmedlast confirmed in an act from 2010
Former directors (16)
-
Former- → 03-09-2025
-
Former01-09-2020 → 30-08-2024
4 events
- 30-08-2024 Resigned· Director
- 01-09-2020 Appointed· Director
- 01-09-2020 Appointed· Managing director
- 01-09-2020 Resigned· Director
-
Former07-11-2019 → 01-05-2024
2 events
- 01-05-2024 Resigned· Director
- 07-11-2019 Appointed· Director
-
Former29-02-2020 → 31-01-2023
2 events
- 31-01-2023 Resigned· Director
- 29-02-2020 Appointed· Director
-
Former01-01-2019 → 01-09-2020
2 events
- 01-09-2020 Resigned· Director
- 01-01-2019 Appointed· Director
-
Former- → 29-02-2020
-
Former06-11-2013 → 07-11-2019
3 events
- 07-11-2019 Resigned· Director
- 01-02-2017 Mandate renewed· Director
- 06-11-2013 Appointed· Director
-
Former25-01-2017 → 01-01-2019
3 events
- 01-01-2019 Resigned· Director
- 31-01-2017 Appointed· Managing director
- 25-01-2017 Appointed· Director
-
Former- → 13-06-2018
-
Former30-09-2015 → 31-01-2017
4 events
- 31-01-2017 Resigned· Director
- 31-01-2017 Resigned· Managing director
- 30-09-2015 Appointed· Director
- 30-09-2015 Appointed· Managing director
-
Former05-11-2012 → 30-09-2015
3 events
- 30-09-2015 Resigned· Director
- 30-09-2015 Resigned· Managing director
- 05-11-2012 Mandate renewed· Director
-
Former01-10-2010 → 06-11-2013
2 events
- 06-11-2013 Resigned· Director
- 01-10-2010 Appointed· Director
-
Former01-08-2012 → 06-11-2013
2 events
- 06-11-2013 Resigned· Director
- 01-08-2012 Appointed· Director
-
Former- → 31-07-2012
-
Former- → 01-10-2010
-
Former- → 30-08-2010
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Ernst et Young Reviseurs d'EntreprisesCurrent Statutory auditor · represented by Wim Van Gasse |
- | 01-07-2012 → present |
| NACE primary | Groothandel in farmaceutische en medische artikelen(46460) |
| Legal form | Public limited company(014) |
| Incorporation | 21-12-1989 |
| Status | Active |
| Postal code | 1831 |
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23015B0030/00N000 | Flanders | 7,487 m² | 1 · 2,662 m² | 23.2 m · 6 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
17-11-2025 Heba Elmorshedy resigns as director
- Heba Elmorshedy, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Heba Elmorshedy",
"address": null,
"birth_date": null
},
"effective_date": "2025-09-03",
"evidence_quote": "De ondergetekenden beslissen eenparig en schriftelijk om: (A) Akte te nemen van het ontslag van Heba Elmorshedy als bestuurder van de Vennootschap met ingang vanaf 3 september 2025 en voor zover noodzakelijk dit ontslag te aanvaarden en te bekrachtigen."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}22-07-2025 Board meeting · Statute amendment · General meeting · Officer appointment
- Publication: 22/07/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Filing: 11/07/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Board meeting: 23/04/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Statute amendment: wijziging delegatiereglement dagelijks bestuur · Algemene Vereniging van de Geneesmiddelenindustrie
- General meeting: 11/06/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Officer appointment: role: bestuurder, start_date: 2025-06-11 · Almirall N.V.
- Officer appointment: role: bestuurder, start_date: 2025-06-11 · Novo Nordisk Pharma N.V.
- Officer appointment: role: bestuurder, start_date: 2025-06-11 · Takeda Belgium N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · Amgen N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · MSD Belgium N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · Roche N.V.
- Officer reappointment: role: bestuurder, start_date: 2025-06-11 · UCB Pharma N.V.
- Officer resignation: role: bestuurder, end_date: 2025-06-11 · Vertex Pharmaceuticals (Netherlands) BV
- Permanent representative: start_date: 16/05/2025 · Paul Lacante
- Permanent representative · Gregory Paton
- Permanent representative · Axel De Muyt
- Permanent representative · Bruno Rabilier
Technical details
{
"facts": [
{
"date": "2025-07-22",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad -22/07/2025 - Annexes du Moniteur belge",
"value": "22/07/2025",
"object": null,
"subject": "e1"
},
{
"date": "2025-07-11",
"type": "filing",
"quote": "neergelegd/ontvangen op 114 JULI 2025",
"value": "11/07/2025",
"object": null,
"subject": "e1"
},
{
"date": "2025-04-23",
"type": "board_meeting",
"quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 23 APRIL 2025",
"value": "23/04/2025",
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "Onderwerp akte: Benoeming bestuurders - wijziging delegatiereglement dagelijks bestuur",
"value": "wijziging delegatiereglement dagelijks bestuur",
"object": null,
"subject": "e1"
},
{
"date": "2025-06-11",
"type": "general_meeting",
"quote": "GEWONE ALGEMENE VERGADERING VAN 11 JUNI 2025",
"value": "11/06/2025",
"object": null,
"subject": "e1"
},
{
"date": "2025-06-11",
"type": "officer_appointment",
"quote": "Benoeming van: Almirall N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e2",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_appointment",
"quote": "Benoeming van: Novo Nordisk Pharma N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e3",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_appointment",
"quote": "Benoeming van: Takeda Belgium N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e4",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 1. Amgen N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 2. MSD Belgium N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e6",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 3. Roche N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e7",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"date": "2025-06-11",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 4. UCB Pharma N.V.",
"value": {
"role": "bestuurder",
"start_date": "2025-06-11"
},
"object": null,
"subject": "e8",
"_value_raw": {
"role": "bestuurder",
"term": null,
"start_date": "11/06/2025"
}
},
{
"type": "officer_resignation",
"quote": "Ontslag van: 1. Vertex Pharmaceuticals (Netherlands) BV",
"value": {
"role": "bestuurder",
"end_date": "2025-06-11"
},
"object": null,
"subject": "e9",
"_value_raw": {
"role": "bestuurder",
"reason": "ontslag",
"end_date": "11/06/2025"
}
},
{
"date": "2025-05-16",
"type": "permanent_representative",
"quote": "Bristol-Myers Squibb Belgium N.V. ... heeft als nieuwe vaste vertegenwoordiger vanaf 16/05/2025 de heer Paul Lacante",
"value": {
"start_date": "16/05/2025"
},
"object": "e10",
"subject": "e11"
},
{
"type": "permanent_representative",
"quote": "Almirall N.V. ... heeft als vaste vertegenwoordiger de heer Gregory Paton",
"value": {},
"object": "e2",
"subject": "e13"
},
{
"type": "permanent_representative",
"quote": "Novo Nordisk Pharma N.V. ... heeft als vaste vertegenwoordiger de heer Axel De Muyt",
"value": {},
"object": "e3",
"subject": "e14"
},
{
"type": "permanent_representative",
"quote": "Takeda Belgium N.V. ... heeft als vaste vertegenwoordiger de heer Bruno Rabilier",
"value": {},
"object": "e4",
"subject": "e15"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 9714,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "company",
"name": "Algemene Vereniging van de Geneesmiddelenindustrie",
"attrs": {
"seat": "Kantersteen 47, 1000 Brussel",
"legal_form": "Vereniging zonder Winstoogmerk",
"short_name": "AVGI"
}
},
{
"id": "e2",
"kbo": "0403.090.131",
"kind": "company",
"name": "Almirall N.V.",
"attrs": {
"seat": "Lenneke Marelaan 4, 1932 Sint-Stevens-Woluwe"
}
},
{
"id": "e3",
"kbo": "0414.695.586",
"kind": "company",
"name": "Novo Nordisk Pharma N.V.",
"attrs": {
"seat": "Alfons Gossetlaan 32E/202, 1702 Groot-Bijgaarden"
}
},
{
"id": "e4",
"kbo": "0403.054.202",
"kind": "company",
"name": "Takeda Belgium N.V.",
"attrs": {
"seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
}
},
{
"id": "e5",
"kbo": "0439.652.401",
"kind": "company",
"name": "Amgen N.V.",
"attrs": {
"seat": "Telecomlaan 5-7, 1831 Diegem"
}
},
{
"id": "e6",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium N.V.",
"attrs": {
"seat": "Vorstlaan 25, 1170 Watermaal-Bosvoorde"
}
},
{
"id": "e7",
"kbo": "0403.088.151",
"kind": "company",
"name": "Roche N.V.",
"attrs": {
"seat": "Dantestraat 75, 1070 Anderlecht"
}
},
{
"id": "e8",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Pharma N.V.",
"attrs": {
"seat": "Researchdreef 60, 1070 Anderlecht"
}
},
{
"id": "e9",
"kbo": "0666.408.905",
"kind": "company",
"name": "Vertex Pharmaceuticals (Netherlands) BV",
"attrs": {
"seat": "Leidsevaart 20, NL - 2013 HA Haarlem"
}
},
{
"id": "e10",
"kbo": "0403.075.184",
"kind": "company",
"name": "Bristol-Myers Squibb Belgium N.V.",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Paul Lacante",
"attrs": {}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "Sally McNab",
"attrs": {}
},
{
"id": "e13",
"kbo": null,
"kind": "person",
"name": "Gregory Paton",
"attrs": {}
},
{
"id": "e14",
"kbo": null,
"kind": "person",
"name": "Axel De Muyt",
"attrs": {}
},
{
"id": "e15",
"kbo": null,
"kind": "person",
"name": "Bruno Rabilier",
"attrs": {}
},
{
"id": "e16",
"kbo": null,
"kind": "company",
"name": "Facing BV",
"attrs": {}
},
{
"id": "e17",
"kbo": null,
"kind": "person",
"name": "Caroline Ven",
"attrs": {}
}
]
}03-01-2025 Act object · Board meeting · Officer appointment · Permanent representative
- Act object: Benoeming Ondervoorzitter Raad van Bestuur - nieuwe vaste vertegenwoordigers Raad van bestuur - wijziging statuten · Algemene Vereniging van de Geneesmiddelenindustrie
- Publication: 03/01/2025 · Algemene Vereniging van de Geneesmiddelenindustrie
- Filing: 23/12/2024 · Algemene Vereniging van de Geneesmiddelenindustrie
- Board meeting: 16/10/2024 · Algemene Vereniging van de Geneesmiddelenindustrie
- Officer appointment: role: ondervoorzitter van de Raad van Bestuur, start_date: 2024-10-16 · Xavier Hormaechea
- Permanent representative: start_date: 25/09/2024 · Marleen Hoebus
- Permanent representative: start_date: 01/10/2024 · Sara Schaufelberger
- Permanent representative: start_date: 14/11/2024 · Angela Thompson
- General meeting: 27/11/2024 · Algemene Vereniging van de Geneesmiddelenindustrie
- Statute amendment: description: Wijziging statuten goedgekeurd door Buitengewone Algemene Vergadering van 27 november 2024, inclusief artikelen 5, 6, 7, 8, 9, 13, 16, 22, 24, 28 en overgangsbepalingen. · Algemene Vereniging van de Geneesmiddelenindustrie
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Onderwerp akte: Benoeming Ondervoorzitter Raad van Bestuur - nieuwe vaste vertegenwoordigers Raad van bestuur - wijziging statuten",
"value": "Benoeming Ondervoorzitter Raad van Bestuur - nieuwe vaste vertegenwoordigers Raad van bestuur - wijziging statuten",
"object": null,
"subject": "e1"
},
{
"date": "2025-01-03",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 03/01/2025 - Annexes du Moniteur belge",
"value": "03/01/2025",
"object": null,
"subject": "e1"
},
{
"date": "2024-12-23",
"type": "filing",
"quote": "neergelegd/ontvangen op 23 12 2024",
"value": "23/12/2024",
"object": null,
"subject": "e1"
},
{
"date": "2024-10-16",
"type": "board_meeting",
"quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 16 OKTOBER 2024",
"value": "16/10/2024",
"object": null,
"subject": "e1"
},
{
"date": "2024-10-16",
"type": "officer_appointment",
"quote": "Op de Raad van Bestuur van 16 oktober 2024 werd de heer Xavier Hormaechea tot ondervoorzitter van de Raad van Bestuur benoemd.",
"value": {
"role": "ondervoorzitter van de Raad van Bestuur",
"start_date": "2024-10-16"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "ondervoorzitter van de Raad van Bestuur",
"term": null,
"start_date": "16/10/2024"
}
},
{
"date": "2024-09-25",
"type": "permanent_representative",
"quote": "Janssen-Cilag N.V. (BE 0415.283.427) heeft als nieuwe vaste vertegenwoordiger vanaf 25/09/2024 mevrouw Marleen Hoebus in opvolging van mevrouw Maria Prado.",
"value": {
"start_date": "25/09/2024"
},
"object": "e3",
"subject": "e4"
},
{
"date": "2024-10-01",
"type": "permanent_representative",
"quote": "Amgen N.V. (BE 0439.652.401) heeft als nieuwe vaste vertegenwoordiger vanaf 01/10/2024 mevrouw Sara Schaufelberger in opvolging van de heer Gabor Sztaniszlav.",
"value": {
"start_date": "01/10/2024"
},
"object": "e6",
"subject": "e7"
},
{
"date": "2024-11-14",
"type": "permanent_representative",
"quote": "AstraZeneca N.V. (BE 0400.165.679) heeft als nieuwe vaste vertegenwoordiger vanaf 14/11/2024 mevrouw Angela Thompson in opvolging van mevrouw Keira Driansky.",
"value": {
"start_date": "14/11/2024"
},
"object": "e9",
"subject": "e10"
},
{
"date": "2024-11-27",
"type": "general_meeting",
"quote": "BUITENGEWONE ALGEMENE VERGADERING VAN 27 NOVEMBER 2024",
"value": "27/11/2024",
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "De voorgestelde wijzigingen aan de statuten werden goedgekeurd door de Buitengewone Algemene Vergadering van 27 november 2024",
"value": {
"description": "Wijziging statuten goedgekeurd door Buitengewone Algemene Vergadering van 27 november 2024, inclusief artikelen 5, 6, 7, 8, 9, 13, 16, 22, 24, 28 en overgangsbepalingen."
},
"object": null,
"subject": "e1"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 41579,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "org",
"name": "Algemene Vereniging van de Geneesmiddelenindustrie",
"attrs": {
"seat": "Kantersteen 47, 1000 Brussel",
"legal_form": "Vereniging zonder Winstoogmerk",
"short_name": "AVGI"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Xavier Hormaechea",
"attrs": {}
},
{
"id": "e3",
"kbo": "0415.283.427",
"kind": "company",
"name": "Janssen-Cilag N.V.",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Marleen Hoebus",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Maria Prado",
"attrs": {}
},
{
"id": "e6",
"kbo": "0439.652.401",
"kind": "company",
"name": "Amgen N.V.",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Sara Schaufelberger",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Gabor Sztaniszlav",
"attrs": {}
},
{
"id": "e9",
"kbo": "0400.165.679",
"kind": "company",
"name": "AstraZeneca N.V.",
"attrs": {}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "Angela Thompson",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Keira Driansky",
"attrs": {}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "Caroline Ven",
"attrs": {}
}
]
}03-01-2025 Board meeting · Officer appointment · Permanent representative · General meeting
- Publication: 03/01/2025 · Association Générale de l'Industrie du Médicament
- Filing: 23/12/2024 · Association Générale de l'Industrie du Médicament
- Board meeting: 16/10/2024 · Association Générale de l'Industrie du Médicament
- Officer appointment: role: Vice-Président, start_date: 2024-10-16 · Xavier Hormaechea
- Permanent representative: start_date: 25/09/2024 · Marleen Hoebus
- Permanent representative: start_date: 01/10/2024 · Sara Schaufelberger
- Permanent representative: start_date: 14/11/2024 · Angela Thompson
- General meeting: 27/11/2024 · Association Générale de l'Industrie du Médicament
- Statute amendment: description: Modifications aux statuts approuvées par l'AGE du 27 novembre 2024, incluant les articles 5 (Admission), 6 (Démission), 7 (Exclusion), 8 (Démission - Exclusion), 9 (Représentation), 13 (Convocations), 16 (Composition), 22 (Procédure), 24 (Règlement d'ordre intérieur), 28 (Cotisations) et dispositions transitoires. · Association Générale de l'Industrie du Médicament
Technical details
{
"facts": [
{
"date": "2025-01-03",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 03/01/2025 - Annexes du Moniteur belge",
"value": "03/01/2025",
"object": null,
"subject": "e1"
},
{
"date": "2024-12-23",
"type": "filing",
"quote": "neergelegd\u0027ontvangan op 23 DEC. 2024",
"value": "23/12/2024",
"object": null,
"subject": "e1"
},
{
"date": "2024-10-16",
"type": "board_meeting",
"quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 16 OCTOBRE 2024",
"value": "16/10/2024",
"object": null,
"subject": "e1"
},
{
"date": "2024-10-16",
"type": "officer_appointment",
"quote": "Lors du Conseil d\u0027administration du 16 octobre 2024, Monsieur Xavier Hormaechea a \u00E9t\u00E9 d\u00E9sign\u00E9 comme Vice-Pr\u00E9sident.",
"value": {
"role": "Vice-Pr\u00E9sident",
"start_date": "2024-10-16"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "Vice-Pr\u00E9sident",
"term": null,
"start_date": "16/10/2024"
}
},
{
"date": "2024-09-25",
"type": "permanent_representative",
"quote": "Janssen-Cilag S.A. (BE 0415.283.427) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 25/09/2024 Madame Marleen Hoebus, succ\u00E9dant \u00E0 Madame Maria Prado.",
"value": {
"start_date": "25/09/2024"
},
"object": "e3",
"subject": "e4"
},
{
"date": "2024-10-01",
"type": "permanent_representative",
"quote": "Amgen S.A. (BE 0439.652.401) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 01/10/2024 Madame Sara Schaufelberger, succ\u00E9dant \u00E0 Monsieur Gabor Sztaniszlav.",
"value": {
"start_date": "01/10/2024"
},
"object": "e6",
"subject": "e7"
},
{
"date": "2024-11-14",
"type": "permanent_representative",
"quote": "AstraZeneca S.A. (BE 0400.165.679) a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 14/11/2024 Madame Angela Thompson, succ\u00E9dant \u00E0 Madame Keira Driansky.",
"value": {
"start_date": "14/11/2024"
},
"object": "e9",
"subject": "e10"
},
{
"date": "2024-11-27",
"type": "general_meeting",
"quote": "ASSEMBLEE GENERALE EXTRAORDINAIRE DU 27 NOVEMBRE 2024",
"value": "27/11/2024",
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "Les modifications propos\u00E9es aux statuts ont \u00E9t\u00E9 approuv\u00E9es par l\u0027Assembl\u00E9e G\u00E9n\u00E9rale Extraordinaire du 27 novembre 2024",
"value": {
"description": "Modifications aux statuts approuv\u00E9es par l\u0027AGE du 27 novembre 2024, incluant les articles 5 (Admission), 6 (D\u00E9mission), 7 (Exclusion), 8 (D\u00E9mission - Exclusion), 9 (Repr\u00E9sentation), 13 (Convocations), 16 (Composition), 22 (Proc\u00E9dure), 24 (R\u00E8glement d\u0027ordre int\u00E9rieur), 28 (Cotisations) et dispositions transitoires."
},
"object": null,
"subject": "e1"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 41680,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "org",
"name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
"attrs": {
"seat": "Cantersteen 47, 1000 Bruxelles",
"legal_form": "Association sans But Lucratif",
"short_name": "AGIM"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Xavier Hormaechea",
"attrs": {}
},
{
"id": "e3",
"kbo": "0415.283.427",
"kind": "company",
"name": "Janssen-Cilag S.A.",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Marleen Hoebus",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Maria Prado",
"attrs": {}
},
{
"id": "e6",
"kbo": "0439.652.401",
"kind": "company",
"name": "Amgen S.A.",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Sara Schaufelberger",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Gabor Sztaniszlav",
"attrs": {}
},
{
"id": "e9",
"kbo": "0400.165.679",
"kind": "company",
"name": "AstraZeneca S.A.",
"attrs": {}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "Angela Thompson",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Keira Driansky",
"attrs": {}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "Caroline Ven",
"attrs": {}
}
]
}21-11-2024 2 directors appointed
- ELMORSHEDY Heba Amgad, Bestuurder
- SCHAUFELBERGER Sara Andrea, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "ELMORSHEDY Heba Amgad",
"address": null,
"birth_date": null
},
"effective_date": "2024-11-07",
"evidence_quote": "De vergadering beslist te benoemen als bestuurder van de Vennootschap, vanaf heden en voor een duur die zes jaar niet te boven gaat: - mevrouw ELMORSHEDY Heba Amgad, geboren te Menia (Egypte) op 23 juli 1984;"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SCHAUFELBERGER Sara Andrea",
"address": null,
"birth_date": null
},
"effective_date": "2024-11-07",
"evidence_quote": "De vergadering beslist te benoemen als bestuurder van de Vennootschap, vanaf heden en voor een duur die zes jaar niet te boven gaat: ... - mevrouw SCHAUFELBERGER Sara Andrea, geboren te Fischenthal (Zwitserland) op 31 maart 1981."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}02-10-2024 Gabor Sztaniszlav resigns as director
- Gabor Sztaniszlav, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gabor Sztaniszlav",
"address": null,
"birth_date": null
},
"effective_date": "2024-08-30",
"evidence_quote": "De ondergetekenden beslissen eenparig en schriftelijk om: (A) Akte te nemen van het ontslag van Gabor Sztaniszlav als bestuurder van de Vennootschap met ingang vanaf 30.08.2024 en voor zover noodzakelijk dit ontslag te aanvaarden en te bekrachtigen. Er wordt aan Gabor Sztanislav voorlopige kwijting ",
"discharge_granted": true
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}05-09-2024 1 director appointed, 1 resigning
- Roman Stampfli, Bestuurder
- Gwenaël Caesens, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gwena\u00EBl Caesens",
"address": null,
"birth_date": null
},
"effective_date": "2024-05-01",
"evidence_quote": "De ondergetekenden beslissen eenparig en schriftelijk om: (A) Akte te nemen van het ontslag van mevrouw Gwena\u00EBl Caesens als bestuurder van de Vennootschap met ingang vanaf 01.05.2024 en voor zover noodzakelijk dit ontslag te aanvaarden en te bekrachtigen. Er wordt aan mevrouw Gwena\u00EBl Caesens voorlop",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Roman Stampfli",
"address": null,
"birth_date": null
},
"evidence_quote": "De ondergetekenden beslissen eenparig en schriftelijk om: De heer Roman Stampfli te benoemen tot bestuurder van de Vennootschap met ingang vanaf de ondertekening van deze besluiten voor een duurtijd van 6 jaar."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}05-06-2023 1 director appointed, 1 resigning
- Paraskevi Florou, Bestuurder
- Adam Stewart Elinoff, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Adam Stewart Elinoff",
"address": null,
"birth_date": null
},
"effective_date": "2023-01-31",
"evidence_quote": "De ondergetekendern beslissen eenparig en schriftelijk om: (A) Akte te nemen van het ontslag van Adam Stewart Elinoff als bestuurder van de Vennootschap met ingang vanaf 31 januari 2023 en voor zover noodzakelijk dit ontslag te aanvaarden en te bekrachtigen. Er wordt aan Adam Stewart Elinoff voorlop",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paraskevi Florou",
"address": null,
"birth_date": null
},
"effective_date": "2023-04-01",
"evidence_quote": "(B) Mevrouw Paraskevi Florou, gedomicilieerd te Zugerstrasse 104, 8810 Horgen Zwitzerland, en geboren op 30 november 1979 te Peiraias, Griekenlard, te benoemen tot bestuurder van de Vennootschap, met ingang vanaf 1 april 2023, voor een termijn van 6 jaar die zal aflopen na de gewone algemene vergade"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}30-04-2021 General meeting · Officer appointment · Officer reappointment · Officer resignation
- Publication: 2021-04-23 · Algemene Vereniging van de Geneesmiddelenindustrie
- Filing: 2021-04-23 · Algemene Vereniging van de Geneesmiddelenindustrie
- General meeting: 2021-03-17 · Algemene Vereniging van de Geneesmiddelenindustrie
- Officer appointment: role: bestuurder, start_date: 2021-03-17 · Takeda Belgium N.V.
- Officer reappointment: role: bestuurder, start_date: 2021-03-17 · AbbVie N.V.
- Officer reappointment: role: bestuurder, start_date: 2021-03-17 · Amgen N.V.
- Officer reappointment: role: bestuurder, start_date: 2021-03-17 · Eli Lilly Benelux N.V.
- Officer reappointment: role: bestuurder, start_date: 2021-03-17 · Pfizer N.V.
- Officer resignation: role: bestuurder, end_date: 2021-03-17 · Merck N.V.
- Permanent representative · Laurerit Henaux
- Officer appointment: role: CEO, belast met het dagelijks bestuur · Caroline Ven
Technical details
{
"facts": [
{
"date": "2021-04-30",
"type": "publication",
"quote": "23 APR. 2021",
"value": "2021-04-23",
"object": null,
"subject": "e1"
},
{
"date": "2021-04-23",
"type": "filing",
"quote": "neergelegd/ontvangen op ... 23 APR. 2021",
"value": "2021-04-23",
"object": null,
"subject": "e1"
},
{
"date": "2021-03-17",
"type": "general_meeting",
"quote": "ALGEMENE VERGADERING VAN 17 MAART 2021",
"value": "2021-03-17",
"object": null,
"subject": "e1"
},
{
"date": "2021-03-17",
"type": "officer_appointment",
"quote": "Benoeming van: 1. Takeda Belgium N.V.",
"value": {
"role": "bestuurder",
"start_date": "2021-03-17"
},
"object": "e1",
"subject": "e2"
},
{
"date": "2021-03-17",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 1. AbbVie N.V.",
"value": {
"role": "bestuurder",
"start_date": "2021-03-17"
},
"object": "e1",
"subject": "e3"
},
{
"date": "2021-03-17",
"type": "officer_reappointment",
"quote": "Herbenoeming van: ... 2. Amgen N.V.",
"value": {
"role": "bestuurder",
"start_date": "2021-03-17"
},
"object": "e1",
"subject": "e4"
},
{
"date": "2021-03-17",
"type": "officer_reappointment",
"quote": "Herbenoeming van: ... 3. Eli Lilly Benelux N.V.",
"value": {
"role": "bestuurder",
"start_date": "2021-03-17"
},
"object": "e1",
"subject": "e5"
},
{
"date": "2021-03-17",
"type": "officer_reappointment",
"quote": "Herbenoeming van: ... 4. Pfizer N.V.",
"value": {
"role": "bestuurder",
"start_date": "2021-03-17"
},
"object": "e1",
"subject": "e6"
},
{
"type": "officer_resignation",
"quote": "Ontslag van: 1. Merck N.V.",
"value": {
"role": "bestuurder",
"end_date": "2021-03-17"
},
"object": "e1",
"subject": "e7"
},
{
"type": "permanent_representative",
"quote": "Takeda Belgium NV heeft als vaste vertegenwoordiger de heer Laurerit Henaux",
"value": null,
"object": "e2",
"subject": "e8"
},
{
"type": "officer_appointment",
"quote": "Caroline Ven CEO, belast met het dagelijks bestuur",
"value": {
"role": "CEO, belast met het dagelijks bestuur"
},
"object": "e1",
"subject": "e9"
}
],
"act_meta": {
"outcome": "review",
"postfix": [
"publication date 2021-04-23 -\u003E edition 2021-04-30"
],
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1820,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "company",
"name": "Algemene Vereniging van de Geneesmiddelenindustrie",
"attrs": {
"seat": "Terhulpsesteenweg 166, 1170 Brussel",
"legal_form": "Vereniging zonder Winstoogmerk",
"short_name": "AVGI"
}
},
{
"id": "e2",
"kbo": "0403.054.202",
"kind": "company",
"name": "Takeda Belgium N.V.",
"attrs": {
"seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
}
},
{
"id": "e3",
"kbo": "0845.096.860",
"kind": "company",
"name": "AbbVie N.V.",
"attrs": {
"seat": "avenue Einstein 14, 1300 Wavre"
}
},
{
"id": "e4",
"kbo": "0439.652.401",
"kind": "company",
"name": "Amgen N.V.",
"attrs": {
"seat": "Telecomlaan 5-7, 1831 Diegem"
}
},
{
"id": "e5",
"kbo": "0406.754.454",
"kind": "company",
"name": "Eli Lilly Benelux N.V.",
"attrs": {
"seat": "Markiesstraat 1, 1000 Brussel"
}
},
{
"id": "e6",
"kbo": "0401.994.823",
"kind": "company",
"name": "Pfizer N.V.",
"attrs": {
"seat": "Pleinlaan 17, 1050 Elsene"
}
},
{
"id": "e7",
"kbo": "0403.047.965",
"kind": "company",
"name": "Merck N.V.",
"attrs": {
"seat": "Brusselsesteenweg 288, 3090 Overijse"
}
},
{
"id": "e8",
"kbo": null,
"flag": "Name \u0027Laurerit\u0027 appears to be an OCR error for \u0027Laurent\u0027, but preserved as printed.",
"kind": "person",
"name": "Laurerit Henaux",
"attrs": {
"address": "avenue des B\u00E9cassines 26, 1160 Brussel",
"birth_date": "1966-04-27",
"birth_place": "Toulouse (Frankrijk)"
}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Caroline Ven",
"attrs": {
"role": "CEO, belast met het dagelijks bestuur"
}
}
]
}30-04-2021 General meeting · Officer appointment · Officer reappointment · Officer resignation
- Publication: 2021-01-01 · Association Générale de l'Industrie du Médicament
- Filing: 2021-04-23 · Association Générale de l'Industrie du Médicament
- General meeting: 2021-03-17 · Association Générale de l'Industrie du Médicament
- Officer appointment: role: administrateur, start_date: 2021-03-17 · Takeda Belgium S.A.
- Officer reappointment: role: administrateur, start_date: 2021-03-17 · AbbVie S.A.
- Officer reappointment: role: administrateur, start_date: 2021-03-17 · Amgen S.A.
- Officer reappointment: role: administrateur, start_date: 2021-03-17 · Eli Lilly Benelux S.A.
- Officer reappointment: role: administrateur, start_date: 2021-03-17 · Pfizer S.A.
- Officer resignation: date: 2021-03-17, role: administrateur · Merck S.A.
- Permanent representative · Laurent Henaux
Technical details
{
"facts": [
{
"date": "2021-04-30",
"type": "publication",
"quote": "1/2021",
"value": "2021-01-01",
"object": null,
"subject": "e1"
},
{
"date": "2021-04-23",
"type": "filing",
"quote": "neergelegd/ontvangen op 23 APR. 2021",
"value": "2021-04-23",
"object": null,
"subject": "e1"
},
{
"date": "2021-03-17",
"type": "general_meeting",
"quote": "ASSEMBLEE GENERALE DU 17 MARS 2021",
"value": "2021-03-17",
"object": null,
"subject": "e1"
},
{
"date": "2021-03-17",
"type": "officer_appointment",
"quote": "Nomination de: 1. Takeda Belgium S.A.",
"value": {
"role": "administrateur",
"start_date": "2021-03-17"
},
"object": "e1",
"subject": "e2"
},
{
"date": "2021-03-17",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 1. AbbVie S.A.",
"value": {
"role": "administrateur",
"start_date": "2021-03-17"
},
"object": "e1",
"subject": "e3"
},
{
"date": "2021-03-17",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 2. Amgen S.A.",
"value": {
"role": "administrateur",
"start_date": "2021-03-17"
},
"object": "e1",
"subject": "e4"
},
{
"date": "2021-03-17",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 3. Eli Lilly Benelux S.A.",
"value": {
"role": "administrateur",
"start_date": "2021-03-17"
},
"object": "e1",
"subject": "e5"
},
{
"date": "2021-03-17",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 4. Pfizer S.A.",
"value": {
"role": "administrateur",
"start_date": "2021-03-17"
},
"object": "e1",
"subject": "e6"
},
{
"date": "2021-03-17",
"type": "officer_resignation",
"quote": "D\u00E9mission de : 1. Merck S.A.",
"value": {
"date": "2021-03-17",
"role": "administrateur"
},
"object": "e1",
"subject": "e7"
},
{
"type": "permanent_representative",
"quote": "Takeda Belgium a d\u00E9sign\u00E9 comme repr\u00E9sentant permanent Monsieur Laurent Henaux",
"value": null,
"object": "e2",
"subject": "e8"
}
],
"act_meta": {
"outcome": "review",
"postfix": [
"publication date 2021-01-01 -\u003E edition 2021-04-30"
],
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1896,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "org",
"name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
"attrs": {
"seat": "chauss\u00E9e de La Hulpe 166, 1170 Bruxelles",
"legal_form": "Association sans But Lucratif",
"short_name": "AGIM"
}
},
{
"id": "e2",
"kbo": "0403.054.202",
"kind": "company",
"name": "Takeda Belgium S.A.",
"attrs": {
"seat": "Leonardo Da Vincilaan 7, 1930 Zaventem"
}
},
{
"id": "e3",
"kbo": "0845.096.860",
"kind": "company",
"name": "AbbVie S.A.",
"attrs": {
"seat": "avenue Einstein 14, 1300 Wavre"
}
},
{
"id": "e4",
"kbo": "0439.652.401",
"kind": "company",
"name": "Amgen S.A.",
"attrs": {
"seat": "Telecomlaan 5-7, 1831 Diegem"
}
},
{
"id": "e5",
"kbo": "0406.754.454",
"kind": "company",
"name": "Eli Lilly Benelux S.A.",
"attrs": {
"seat": "rue du Marquis 1, 1000 Bruxelles"
}
},
{
"id": "e6",
"kbo": "0401.994.823",
"kind": "company",
"name": "Pfizer S.A.",
"attrs": {
"seat": "boulevard de la Plaine 17, 1050 Ixelles"
}
},
{
"id": "e7",
"kbo": "0403.047.965",
"kind": "company",
"name": "Merck S.A.",
"attrs": {
"seat": "Brusselsesteenweg 288, 3090 Overijse"
}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Laurent Henaux",
"attrs": {
"address": "avenue des B\u00E9cassines 26, 1160 Bruxelles",
"birth_date": "1966-04-27",
"birth_place": "Toulouse (France)"
}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Caroline Ven",
"attrs": {
"role": "CEO, charg\u00E9 de la gestion journali\u00E8re"
}
}
]
}18-09-2020 2 directors appointed, 2 resigning, 1 reappointed
- Gabor Sztaniszláv, Bestuurder
- Gabor Sztaniszláv, Gedelegeerd bestuurder
- Catherine Boutremans, Bestuurder
- Gabor Sztaniszláv, Bestuurder
- Wim Van Gasse, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Wim Van Gasse",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0446334711",
"name": "Ernst \u0026 Young Bedrijfsrevisoren",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2018-07-01",
"evidence_quote": "Erkennen dat het mandaat van de commissaris van de Vennootschap een einde nam op 30 juni 2018 en bekrachtigen dat Emst \u0026 Young Bedrijfsrevisoren, een burgerlijke vennootschap die de vorm van een co\u00F6peratieve vennootschap met beperkte aansprakelijkheid naar Belgisch recht heeft aangenomen, met maatsc"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Catherine Boutremans",
"address": null,
"birth_date": null
},
"effective_date": "2020-09-01",
"evidence_quote": "Akte te nemen van het ontslag van mevrouw Catherine Boutremans als bestuurder van de Vennootschap met ingang vanaf 1 september 2020 en zover noodzakelijk dit ontslag te aanvaarden en te bekrachtigen. Er wordt aan mevrouw Catherine Boutremans voorlopige kwijting verleend voor de uitoefening van haar ",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gabor Sztaniszl\u00E1v",
"address": null,
"birth_date": null
},
"effective_date": "2020-09-01",
"evidence_quote": "De heer Gabor Sztaniszl\u00E1v, geboren op 14 augustus 1976 te Budapest (Hongarije) en die conform artikel 2:54 WVV woonplaatskeuze doet op de zetel van de Vennootschap, te benoemen tot bestuurder van de Vennootschap, met ingang vanaf 1 september 2020 en eindigerid net na de algemene aandeelhoudersvergad"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Gabor Sztaniszl\u00E1v",
"address": null,
"birth_date": null
},
"effective_date": "2020-09-01",
"evidence_quote": "De raad van bestuur besluit om de heer Gabor Sztaniszl\u00E1v, d\u00EDe conform artikel 2:54 WVW woonplaatskeuze doet op de zetel van de Vennootschap, te benoemen als gedelegeerd bestuurder van de Vennootschap en voorzitter van de raad var\u0131 bestuur van de Vennootschap met ingang vanaf 1 september 2020 en dit "
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gabor Sztaniszl\u00E1v",
"address": null,
"birth_date": null
},
"effective_date": "2020-09-01",
"evidence_quote": "De raad van bestuur rieemt akte van het ontslag van mevrouw Catherine Boutremans als bestuurder en gedelegeerd bestuurder van de Vennootschap er\u0131 als voorzitter van de raad van bestuur van de Vennootschap."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}25-08-2020 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}05-03-2020 1 director appointed, 1 resigning
- Adam Stewart Elinoff, Bestuurder
- Justin Claeys, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Justin Claeys",
"address": null,
"birth_date": null
},
"effective_date": "2020-02-29",
"evidence_quote": "De ondergetekenden beslissen eenparig en schriftelijk om: (A) Akte te nemen van het ontslag van de heer Justin Claeys als bestuurder van de Vennootschap met ingang vanaf 29 februari 2020 en zover noodzakelijk dit ontslag te aanvaarden en te bekrachtigen. Er wordt aan de heer Justin Claeys voorlopige",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Adam Stewart Elinoff",
"address": null,
"birth_date": null
},
"effective_date": "2020-02-29",
"evidence_quote": "(B) De heer Adam Stewart Elinoff, geboren op 22 januari 1977 te New York (USA) en die conform artike 2:54 WVV woonplaatskeuze doet op de zetel van de Vennootschap, te benoemen tot bestuurder van de Vennootschap, met ingang vanaf 29 februari 2020 en eindigend net na de algemene aandeelhoudersvergader"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}11-12-2019 1 director appointed, 1 resigning
- Gwenaël Caesens, Bestuurder
- Virginie Saillard-Drouet, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Virginie Saillard-Drouet",
"address": null,
"birth_date": null
},
"effective_date": "2019-11-07",
"evidence_quote": "De ondergetekenden beslissen eenparig en schriftelijk om: (A) Akte te nemen van het ontslag van mevrouw Virginie Saillard-Drouet als bestuurder van de Vennootschap met ingang vanaf heden en zover noodzakelijk dit ontslag te aanvaarden en te bekrachtigen. Er wordt aan mevrouw Virginie Saillard-Drouet",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gwena\u00EBl Caesens",
"address": null,
"birth_date": null
},
"effective_date": "2019-11-07",
"evidence_quote": "(B) Mevrouw Gwena\u00EBl Caesens, gedomicilieerd te 1170 Watermaal-Bosvoorde, Avenue Charles Michiels 176 b.17 en geboren op 10 maart 1987 te Ukkel, te benoemen tot bestuurder van de Vennootschap, met ingang vanaf heden, voor een termijn van 6 jaar die zal aflopen na de algemene aandeelhoudersvergadering"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}20-03-2019 1 director appointed, 1 resigning
- Catherine Boutremans, Bestuurder
- Corinne Buffet, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Corinne Buffet",
"address": null,
"birth_date": null
},
"effective_date": "2019-01-01",
"evidence_quote": "De ondergetekenden beslissen eenparig en schriftelijk om: (A) Akte te nemen van het ontslag van mevrouw Corinne Buffet als bestuurder van de Vennootschap met ingang vanaf 1 januari 2019 en zover noodzakelijk dit ontslag te aanvaarden en te bekrachtigen. Er wordt aan mevrouw Corinne Buffet voorlopige",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Catherine Boutremans",
"address": null,
"birth_date": null
},
"effective_date": "2019-01-01",
"evidence_quote": "(B) Mevrouw Catherine Boutremans, gedomicilieerd te 1050 Brussel, Avenue Emile de Beco 47 en geboren op 8 september 1975 te Bergen, te benoemen tot bestuurder van de Vennootschap, met ingang vanaf 1 januari 2019, voor een termijn van 6 jaar die zal aflopen na de algemene aandeelhoudersvergadering te"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}27-12-2018 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}01-08-2018 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}09-07-2018 General meeting · Officer appointment · Officer reappointment · Officer resignation
- Publication: 09/07/2018 · Association Générale de l'Industrie du Médicament
- Filing: 20/06/2018 · Association Générale de l'Industrie du Médicament
- General meeting: 23/03/2018 · Association Générale de l'Industrie du Médicament
- Officer appointment: role: Membre du Conseil d'administration, start_date: 2018-03-23 · Amgen S.A.
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2018-03-23 · AbbVie S.A.
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2018-03-23 · Celgene S.P.R.L.
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2018-03-23 · Eli Lilly Benelux S.A.
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2018-03-23 · Pfizer S.A.
- Officer resignation: date: 2018-03-23, role: Membre du Conseil d'administration · Boehringer Ingelheim SCS
- Board meeting: 30/05/2018 · Association Générale de l'Industrie du Médicament
- Officer appointment: role: Président du Conseil d'administration, term: deux ans, start_date: 2018-05-30 · Pfizer S.A.
- Officer appointment: role: Vice-Président du Conseil d'administration, term: deux ans, start_date: 2018-05-30 · MSD Belgium
Technical details
{
"facts": [
{
"date": "2018-07-09",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 09/07/2018",
"value": "09/07/2018",
"object": null,
"subject": "e1"
},
{
"date": "2018-06-20",
"type": "filing",
"quote": "neergelegd/onvangen od 20 JUM 2018",
"value": "20/06/2018",
"object": null,
"subject": "e1"
},
{
"date": "2018-03-23",
"type": "general_meeting",
"quote": "ASSEMBLEE GENERALE DU 23 MARS 2018",
"value": "23/03/2018",
"object": null,
"subject": "e1"
},
{
"date": "2018-03-23",
"type": "officer_appointment",
"quote": "Nomination de : 1. Amgen S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2018-03-23"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"term": null,
"start_date": "23/03/2018"
}
},
{
"date": "2018-03-23",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 1. AbbVie S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2018-03-23"
},
"object": "e1",
"subject": "e3",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"term": null,
"start_date": "23/03/2018"
}
},
{
"date": "2018-03-23",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 2. Celgene S.P.R.L.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2018-03-23"
},
"object": "e1",
"subject": "e4",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"term": null,
"start_date": "23/03/2018"
}
},
{
"date": "2018-03-23",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 3. Eli Lilly Benelux S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2018-03-23"
},
"object": "e1",
"subject": "e5",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"term": null,
"start_date": "23/03/2018"
}
},
{
"date": "2018-03-23",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 4. Pfizer S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2018-03-23"
},
"object": "e1",
"subject": "e6",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"term": null,
"start_date": "23/03/2018"
}
},
{
"date": "2018-03-23",
"type": "officer_resignation",
"quote": "D\u00E9mission de: 1. Boehringer Ingelheim SCS",
"value": {
"date": "2018-03-23",
"role": "Membre du Conseil d\u0027administration"
},
"object": "e1",
"subject": "e7",
"_value_raw": {
"date": "23/03/2018",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2018-05-30",
"type": "board_meeting",
"quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 30 MAI 2018",
"value": "30/05/2018",
"object": null,
"subject": "e1"
},
{
"date": "2018-05-30",
"type": "officer_appointment",
"quote": "Pfizer ... a \u00E9t\u00E9 \u00E9lue pr\u00E9sident ... pour un mandat de deux ans",
"value": {
"role": "Pr\u00E9sident du Conseil d\u0027administration",
"term": "deux ans",
"start_date": "2018-05-30"
},
"object": "e1",
"subject": "e6",
"_value_raw": {
"role": "Pr\u00E9sident du Conseil d\u0027administration",
"term": "deux ans",
"start_date": "30/05/2018"
}
},
{
"date": "2018-05-30",
"type": "officer_appointment",
"quote": "MSD Belgium ... a \u00E9t\u00E9 \u00E9lue Vice-Pr\u00E9sident ... pour un mandat de deux ans",
"value": {
"role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
"term": "deux ans",
"start_date": "2018-05-30"
},
"object": "e1",
"subject": "e8",
"_value_raw": {
"role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
"term": "deux ans",
"start_date": "30/05/2018"
}
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1885,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "org",
"name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
"attrs": {
"seat": "chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES",
"legal_form": "Association sans But Lucratif",
"short_name": "AGIM"
}
},
{
"id": "e2",
"kbo": "0439.652.401",
"kind": "company",
"name": "Amgen S.A.",
"attrs": {
"seat": "Telecomlaan 5-7, 1831 Diegem"
}
},
{
"id": "e3",
"kbo": "0845.096.860",
"kind": "company",
"name": "AbbVie S.A.",
"attrs": {
"seat": "avenue Einstein 14, 1300 Wavre"
}
},
{
"id": "e4",
"kbo": "0882.012.387",
"kind": "company",
"name": "Celgene S.P.R.L.",
"attrs": {
"seat": "Place du Luxembourg 1, 1420 Braine-l\u0027Alleud"
}
},
{
"id": "e5",
"kbo": "0406.754.454",
"kind": "company",
"name": "Eli Lilly Benelux S.A.",
"attrs": {
"seat": "rue du Marquis 1, 1000 Bruxelles"
}
},
{
"id": "e6",
"kbo": "0401.994.823",
"kind": "company",
"name": "Pfizer S.A.",
"attrs": {
"seat": "boulevard de la Plaine 17, 1050 Ixelles"
}
},
{
"id": "e7",
"kbo": "0435.953.632",
"kind": "company",
"name": "Boehringer Ingelheim SCS",
"attrs": {
"seat": "avenue Ariane 16, 1200 Woluwe-Saint-Lambert"
}
},
{
"id": "e8",
"kbo": null,
"kind": "company",
"name": "MSD Belgium",
"attrs": {}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Karel Van De Sompel",
"attrs": {}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "Clarisse Lhoste",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Catherine Rutten",
"attrs": {}
}
]
}13-06-2018 1 director appointed, 1 resigning
- Justin Gary CLAEYS, Bestuurder
- Christopher Ian McKinlay, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Christopher Ian McKinlay",
"address": null,
"birth_date": null
},
"evidence_quote": "De vergadering neemt kennis van en aanvaardt het ontslag van de volgende bestuurder: - de heer Christopher lan McKinlay."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Justin Gary CLAEYS",
"address": null,
"birth_date": null
},
"effective_date": "2018-05-15",
"evidence_quote": "De vergadering beslist te benoemen als bestuurder van de Verinootschap, variaf vijftien mei tweeduizend achttien er voor een duur die zes jaar niet te boven gaat: - de heer CLAEYS Justin Gary, wonende te Schlossberg 28, 6343 Risch, Canton Zug, Zwitserland."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}22-03-2018 Registered office moved from Brussel to Diegem
- Arianelaan 5, 1200 Brussel → Telecomlaan 5-7, 1831 Diegem
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Diegem",
"region": "Vlaams Gewest",
"street": "Telecomlaan",
"country": "BE",
"postcode": "1831",
"box_number": null,
"street_number": "5-7"
},
"old_address": {
"city": "Brussel",
"region": "Brussels Hoofdstedelijk Gewest",
"street": "Arianelaan",
"country": "BE",
"postcode": "1200",
"box_number": null,
"street_number": "5"
},
"effective_date": "2018-04-01",
"evidence_quote": "de zetel van de Vennootschap te verplaatsen van Arianelaan 5, 1200 Brussel (Sint-Lambrechts-Woluwe) naar Telecomlaan 5-7, 1831 Diegem met ingang van 1 april 2018"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}01-03-2017 2 directors appointed, 2 resigning, 3 reappointed
- Corinne Buffet, Bestuurder
- Corinne Buffet, Gedelegeerd bestuurder
- Yves Zinggeler, Bestuurder
- Yves Zinggeler, Gedelegeerd bestuurder
- Wim Van Gasse, Commissaris
- Virginie Saillard-Drouet, Bestuurder
- Christopher McKinlay, Bestuurder
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Wim Van Gasse",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0446334711",
"name": "Enst \u0026 Young",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2016-07-01",
"evidence_quote": "De aandeelhouders nemen kennis van het feit dat Dhr. Herman Van den Abeele werd vervangen door Dhr.: Wim Van Gasse, ingeschreven als bednjfsrevisor in het openbare register van het instituut van de Bedrijfsrevisoren onder het nummer A02276, als vaste vertegenwoordiger van Enst \u0026 Young, en dit met in"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Yves Zinggeler",
"address": null,
"birth_date": null
},
"effective_date": "2017-01-31",
"evidence_quote": "De aandeelhouders nemen eenparig en schriftelijk kennis van het ontslag van Dhr. Yves Zinggeler als bestuurder van de vennootschap met ingang vanaf 31 januari 2017. De aandeelhouders danken Dhr. Yves Zinggeler voor de uitoeferiing van zijn mandaat als bestuurder.",
"discharge_granted": false
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Virginie Saillard-Drouet",
"address": null,
"birth_date": null
},
"effective_date": "2017-02-01",
"evidence_quote": "De aandeelhouders beslissen unaniem en schriftelijk: (i) om (a) Mevr. Virginie Saillard-Drouet, gedomicilieerd te Woudlaan 51, 1970 Wezembeek Oppem, Belgi\u00EB en (b) Dhr. Christopher McKinlay, gedomicilieerd te Sor\u0131nenheim 10, 6344 Meierskappel, Zwitserland, te herbenoemen als bestuurders van de vennoo"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Christopher McKinlay",
"address": null,
"birth_date": null
},
"effective_date": "2017-02-01",
"evidence_quote": "De aandeelhouders beslissen unaniem en schriftelijk: (i) om (a) Mevr. Virginie Saillard-Drouet, gedomicilieerd te Woudlaan 51, 1970 Wezembeek Oppem, Belgi\u00EB en (b) Dhr. Christopher McKinlay, gedomicilieerd te Sor\u0131nenheim 10, 6344 Meierskappel, Zwitserland, te herbenoemen als bestuurders van de vennoo"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Corinne Buffet",
"address": null,
"birth_date": null
},
"effective_date": "2017-01-25",
"evidence_quote": "De aandeelhouders beslissen unaniem en schriftelijk: (ii) om Mevr. Corinne Buffet, gedomicilieerd te 45 avenue Augustin Dumont, 92240 Malakoff, Frankrijk, te benoemen als bestuurder van de vennootschap, met retroactief effect vanaf 25 januari 2017."
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Yves Zinggeler",
"address": null,
"birth_date": null
},
"effective_date": "2017-01-31",
"evidence_quote": "De bestuurders nemen akte van het ontslag van de heer Yves Zinggeler als gedelegeerd bestuurder met ingang vanaf 31 januari 2017. De bestuurders wensen de heer Yves Zinggeler te bedanken voor de uitoefening van zijn mandaat als gedelegeerd bestuurder.",
"discharge_granted": false
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Corinne Buffet",
"address": null,
"birth_date": null
},
"effective_date": "2017-01-31",
"evidence_quote": "Na beraadslaging, heeft de Raad van Bestuur unaniem: (i) besloten om de mevrouw Corinne Buffet, gedomicilieerd te 45 avenue Augustin Dumont, 92240 Malakoff, Frankrijk, te benoemen als gedelegeerd bestuurder van de vennootschap in de zin van artikel 525 van het Wetboek van Vennootschappen, met ingang"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}16-10-2015 2 directors appointed, 2 resigning, 1 reappointed
- Yves Zinggeler, Bestuurder
- Yves Zinggeler, Gedelegeerd bestuurder
- Jean-Christophe Bencteux, Bestuurder
- Jean-Christophe Bencteux, Gedelegeerd bestuurder
- Herman Van den Abeele, Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Herman Van den Abeele",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0446334711",
"name": "Ernst \u0026 Young Bedrijfsrevisoren",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2015-07-01",
"evidence_quote": "De aandeelhouders beslissen unaniem en schriftelijk om Ernst \u0026 Young Bedrijfsrevisoren, een burgerlijke vennootschap die de vorm van een co\u00F6peratieve vennootschap met beperkte aansprakelijkheid naar Belgisch recht heeft aangenomen, met maatschappelijke zetel te De Kleetlaan 2, 1831 Diegem (Belgi\u00EB), "
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean-Christophe Bencteux",
"address": null,
"birth_date": null
},
"effective_date": "2015-09-30",
"evidence_quote": "De aandeelhouders nemen akte van het ontslag van de heer Jean-Christophe Bencteux als bestuurder vani de vennootschap met ingang van 30 september 2015. De aandeelhouders danken de heer Bencteux voor zijn diensten voor de vennootschap in het kader van de uitoefening van zijn mandaat als bestuurder. D"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Yves Zinggeler",
"address": null,
"birth_date": null
},
"effective_date": "2015-09-30",
"evidence_quote": "De aandeelhouders beslissen unaniem en schriftelijk: (i) om Yves Zinggeler, gedomicilieerd te Stijn Streuvelslaan 9, 3080 Tervuren, te benoemen als bestuurder van de vennootschap, met ingang vanaf 30 september 2015."
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Jean-Christophe Bencteux",
"address": null,
"birth_date": null
},
"effective_date": "2015-09-30",
"evidence_quote": "De bestuurders nemen akte van het ontslag van de heer Jean-Christophe Bencteux als gedelegeerd bestuurder, hetgeen in werking treedt vanaf 30 september 2015."
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Yves Zinggeler",
"address": null,
"birth_date": null
},
"effective_date": "2015-09-30",
"evidence_quote": "Na beraadslaging, heeft de Raad van Bestuur unaniem: (i) besloten om de heer Yves Zinggeler, gedomicilieerd te Stijn Streuvelslaan 9, 3080 Tervuren, te benoemen als gedelegeerd bestuurder van de vennootschap in de zin van artikel 525 van het Wetboek van Vennootschappen, met effect vanaf 30 september"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}04-12-2013 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2013-11-06",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
},
"signature_regime": "joint_two",
"special_mandates": [
{
"quote": "Bijzondere volmacht werd verleend aan mevrouw Marie Georgy en de heer Michel Bonne, woonstkeuze gedaan hebbende te Van Bael \u0026 Bellis met zetel te 165 Louisalaan, allen individueel bevoegd, evenals aan hun bedienden, aangestelden en lasthebbers, met mogelijkheid tot indeplaatsstelling, teneinde de vervulling van de formaliteiten bij een ondernemingsloket met het oog op de inschrijving/aanpassing van de gegevens in de Kruispuntbank van Ondernemingen, en, desgevallend, bij de Administratie van de Belasting over de Toegevoegde Waarde, te verzekeren.",
"holder_kbo": null,
"holder_name": "mevrouw Marie Georgy en de heer Michel Bonne",
"scope_categories": [
"KBO",
"tax",
"filing"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}27-11-2013 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}05-11-2012 1 director appointed, 1 resigning, 2 reappointed
- Frank Carsten Thiel, Bestuurder
- Rolf Karl-Heinz Hoffman, Bestuurder
- Jean-Christophe Bencteux, Bestuurder
- Herman Van den Abeele, Commissaris
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Rolf Karl-Heinz Hoffman",
"address": null,
"birth_date": null
},
"effective_date": "2012-07-31",
"evidence_quote": "De aandeelhouder neemt akte van het ontslag van de heer Rolf Karl-Heinz Hoffman met ingang op 31 juli 2012 om 23:59 uur, als bestuurder van de vennootschap."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Frank Carsten Thiel",
"address": null,
"birth_date": null
},
"effective_date": "2012-08-01",
"evidence_quote": "De aandeelhouder beslist schriftelijk: (i) om Frank Carsten Thiel, gedomicilieerd te Brunn\u00E4ckerstrasse 24, 5618 Bettwil/Aargau, Zwitserland, als bestuurder van de vennootschap te benoemen, met ingang vanaf 1 augustus 2012 om 00:00 uur."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean-Christophe Bencteux",
"address": null,
"birth_date": null
},
"evidence_quote": "De aandeelhouder beslist schriftelijk om het mandaat van bestuurder van de heer Jean-Christophe Bencteux te vernieuwen tot 1 oktober 2016."
},
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Herman Van den Abeele",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0446334711",
"name": "Ernst\u0026Young Bedrijfsrevisoren",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2012-07-01",
"evidence_quote": "De aandeelhouder beslist schriftelijk om \u0022Ernst\u0026Young Bedrijfsrevisoren\u0022... vertegenwoordigd door haar permanente vertegenwoordiger, Herman Van den Abeele... te verlengen als commissaris van de \u0027vennootschap met ingang vanaf 1 juli 2012 en voor een periode van drie jaar."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}04-06-2012 Act object · General meeting · Officer appointment · Officer reappointment
- Act object: Changements Conseil d'administration - Nomination Président et Vice-Président du Conseil d'administration · Association Générale de l'Industrie du Médicament
- Publication: 04/06/2012 · Association Générale de l'Industrie du Médicament
- Filing: 23/05/2012 · Association Générale de l'Industrie du Médicament
- General meeting: 23/03/2012 · Association Générale de l'Industrie du Médicament
- Officer appointment: role: Membre du Conseil d'administration, start_date: 2012-03-23 · Amgen S.A.
- Officer appointment: role: Membre du Conseil d'administration, start_date: 2012-03-23 · Therabel Pharma S.A.
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2012-03-23 · Abbott S.A.
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2012-03-23 · Eli Lilly Benelux S.A.
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2012-03-23 · Pfizer S.A.
- Officer resignation: date: 2012-03-23, role: Membre du Conseil d'administration · AstraZeneca S.A.
- Officer resignation: date: 2012-03-23, role: Membre du Conseil d'administration · Sanofi Pasteur MSD S.A.
- Board meeting: 09/05/2012 · Association Générale de l'Industrie du Médicament
- Officer appointment: role: Président du Conseil d'administration, term: 2 ans, start_date: 2012-05-09 · Janssen-Cilag
- Officer appointment: role: Vice-Président du Conseil d'administration, term: 2 ans, start_date: 2012-05-09 · Eli Lilly Benelux S.A.
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Changements Conseil d\u0027administration - Nomination Pr\u00E9sident et Vice-Pr\u00E9sident du Conseil d\u0027administration",
"value": "Changements Conseil d\u0027administration - Nomination Pr\u00E9sident et Vice-Pr\u00E9sident du Conseil d\u0027administration",
"object": null,
"subject": "e1"
},
{
"date": "2012-06-04",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 04/06/2012",
"value": "04/06/2012",
"object": null,
"subject": "e1"
},
{
"date": "2012-05-23",
"type": "filing",
"quote": "Groffe 23 MEI 2012",
"value": "23/05/2012",
"object": null,
"subject": "e1"
},
{
"date": "2012-03-23",
"type": "general_meeting",
"quote": "ASSEMBLEE GENERALE DU 23 MARS 2012",
"value": "23/03/2012",
"object": null,
"subject": "e1"
},
{
"date": "2012-03-23",
"type": "officer_appointment",
"quote": "Election de 5 nouveaux membres du Conseil d\u0027administration ... 1. Amgen S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2012-03-23"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "23/03/2012"
}
},
{
"date": "2012-03-23",
"type": "officer_appointment",
"quote": "Election de 5 nouveaux membres du Conseil d\u0027administration ... 2. Therabel Pharma S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2012-03-23"
},
"object": "e1",
"subject": "e3",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "23/03/2012"
}
},
{
"date": "2012-03-23",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: ... 1. Abbott S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2012-03-23"
},
"object": "e1",
"subject": "e4",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "23/03/2012"
}
},
{
"date": "2012-03-23",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: ... 2. Eli Lilly Benelux S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2012-03-23"
},
"object": "e1",
"subject": "e5",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "23/03/2012"
}
},
{
"date": "2012-03-23",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: ... 3. Pfizer S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2012-03-23"
},
"object": "e1",
"subject": "e6",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "23/03/2012"
}
},
{
"date": "2012-03-23",
"type": "officer_resignation",
"quote": "D\u00E9mission de : ... 1. AstraZeneca S.A.",
"value": {
"date": "2012-03-23",
"role": "Membre du Conseil d\u0027administration"
},
"object": "e1",
"subject": "e7",
"_value_raw": {
"date": "23/03/2012",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2012-03-23",
"type": "officer_resignation",
"quote": "D\u00E9mission de : ... 2. Sanofi Pasteur MSD S.A.",
"value": {
"date": "2012-03-23",
"role": "Membre du Conseil d\u0027administration"
},
"object": "e1",
"subject": "e8",
"_value_raw": {
"date": "23/03/2012",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2012-05-09",
"type": "board_meeting",
"quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 9 MAI 2012",
"value": "09/05/2012",
"object": null,
"subject": "e1"
},
{
"date": "2012-05-09",
"type": "officer_appointment",
"quote": "Lors du Conseil d\u0027administration du 9 mai 2012 Janssen-Cilag ... a \u00E9t\u00E9 \u00E9lue Pr\u00E9sident",
"value": {
"role": "Pr\u00E9sident du Conseil d\u0027administration",
"term": "2 ans",
"start_date": "2012-05-09"
},
"object": "e1",
"subject": "e9",
"_value_raw": {
"role": "Pr\u00E9sident du Conseil d\u0027administration",
"term": "2 ans",
"start_date": "09/05/2012"
}
},
{
"date": "2012-05-09",
"type": "officer_appointment",
"quote": "Lors du Conseil d\u0027administration du 9 mai 2012 ... Eli Lilly Benelux ... a \u00E9t\u00E9 \u00E9lue Vice-Pr\u00E9sident",
"value": {
"role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
"term": "2 ans",
"start_date": "2012-05-09"
},
"object": "e1",
"subject": "e5",
"_value_raw": {
"role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
"term": "2 ans",
"start_date": "09/05/2012"
}
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1985,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "org",
"name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
"attrs": {
"seat": "ohauss\u00E9e de La Hulpe 166, 1170 BRUXELLES",
"legal_form": "Association sans But Lucratif",
"short_name": "AGIM"
}
},
{
"id": "e2",
"kbo": "0439.652.401",
"kind": "company",
"name": "Amgen S.A.",
"attrs": {
"seat": "avenue Ariane 5, 1200 Bruxelles"
}
},
{
"id": "e3",
"kbo": "0420.515.586",
"kind": "company",
"name": "Therabel Pharma S.A.",
"attrs": {
"seat": "rue Egide Van Ophem 108, 1180 Uccle"
}
},
{
"id": "e4",
"kbo": "0403.044.007",
"kind": "company",
"name": "Abbott S.A.",
"attrs": {
"seat": "avenue Einstein 14, 1300 Wavre"
}
},
{
"id": "e5",
"kbo": "0406.754.454",
"kind": "company",
"name": "Eli Lilly Benelux S.A.",
"attrs": {
"seat": "rue de l\u0027Etuve 52, 1000 Bruxelles"
}
},
{
"id": "e6",
"kbo": "0401.994.823",
"kind": "company",
"name": "Pfizer S.A.",
"attrs": {
"seat": "boulevard de la Plaine 17, 1050 Bruxelles"
}
},
{
"id": "e7",
"kbo": "0400.165.679",
"kind": "company",
"name": "AstraZeneca S.A.",
"attrs": {
"seat": "rue Egide Van Ophem 110, 1180 Bruxelles"
}
},
{
"id": "e8",
"kbo": "0402.506.646",
"kind": "company",
"name": "Sanofi Pasteur MSD S.A.",
"attrs": {
"seat": "avenue Jules Bordet 13, 1140 Bruxelles"
}
},
{
"id": "e9",
"kbo": null,
"kind": "company",
"name": "Janssen-Cilag",
"attrs": {}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "Sonja Willems",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Patricia Lanssiers",
"attrs": {}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "Leo Neels",
"attrs": {
"role": "Directeur g\u00E9n\u00E9ral charg\u00E9 de la gestion journali\u00E8re"
}
}
]
}03-05-2011 Deed date · General meeting · Officer appointment · Officer reappointment
- Publication: 03/05/2011
- Deed date: 20/04/2011
- General meeting: 25/03/2011
- Officer appointment: role: Conseil d'administration, start_date: 2011-03-25 · Novartis Pharma S.A.
- Officer reappointment: role: Conseil d'administration, start_date: 2011-03-25 · GlaxoSmithKline S.A.
- Officer reappointment: role: Conseil d'administration, start_date: 2011-03-25 · Janssen-Cilag S.A.
- Officer reappointment: role: Conseil d'administration, start_date: 2011-03-25 · Roche S.A.
- Officer reappointment: role: Conseil d'administration, start_date: 2011-03-25 · Sanofi-Aventis Belgium S.A.
- Officer resignation: date: 2011-03-25, role: Conseil d'administration · Amgen S.A.
- Auditor appointment: role: commissaire, term: trois ans, start_date: 25/03/2011 · BDO Réviseurs d'entreprises SCRL
Technical details
{
"facts": [
{
"date": "2011-05-03",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 03/05/2011",
"value": "03/05/2011",
"object": null,
"subject": null
},
{
"date": "2011-04-20",
"type": "deed_date",
"quote": "BRUXELLES 20 AVR. 2011",
"value": "20/04/2011",
"object": null,
"subject": null
},
{
"date": "2011-03-25",
"type": "general_meeting",
"quote": "ASSEMBLEE GENERALE DU 25 MARS 2011",
"value": "25/03/2011",
"object": null,
"subject": null
},
{
"date": "2011-03-25",
"type": "officer_appointment",
"quote": "Nomination de: Novartis Pharma S.A.",
"value": {
"role": "Conseil d\u0027administration",
"start_date": "2011-03-25"
},
"object": null,
"subject": "e1",
"_value_raw": {
"role": "Conseil d\u0027administration",
"start_date": "25/03/2011"
}
},
{
"date": "2011-03-25",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de : 1. GlaxoSmithKline S.A.",
"value": {
"role": "Conseil d\u0027administration",
"start_date": "2011-03-25"
},
"object": null,
"subject": "e2",
"_value_raw": {
"role": "Conseil d\u0027administration",
"start_date": "25/03/2011"
}
},
{
"date": "2011-03-25",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de : 2. Janssen-Cilag S.A.",
"value": {
"role": "Conseil d\u0027administration",
"start_date": "2011-03-25"
},
"object": null,
"subject": "e3",
"_value_raw": {
"role": "Conseil d\u0027administration",
"start_date": "25/03/2011"
}
},
{
"date": "2011-03-25",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de : 3. Roche S.A.",
"value": {
"role": "Conseil d\u0027administration",
"start_date": "2011-03-25"
},
"object": null,
"subject": "e4",
"_value_raw": {
"role": "Conseil d\u0027administration",
"start_date": "25/03/2011"
}
},
{
"date": "2011-03-25",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de : 4. Sanofi-Aventis Belgium S.A.",
"value": {
"role": "Conseil d\u0027administration",
"start_date": "2011-03-25"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "Conseil d\u0027administration",
"start_date": "25/03/2011"
}
},
{
"date": "2011-03-25",
"type": "officer_resignation",
"quote": "D\u00E9mission de: Amgen S.A.",
"value": {
"date": "2011-03-25",
"role": "Conseil d\u0027administration"
},
"object": null,
"subject": "e6",
"_value_raw": {
"date": "25/03/2011",
"role": "Conseil d\u0027administration"
}
},
{
"date": "2011-03-25",
"type": "auditor_appointment",
"quote": "L\u0027Assembl\u00E9e g\u00E9n\u00E9rale confirme la reconduction de la nomination pour une p\u00E9riode de trois ans du commissaire BDO R\u00E9viseurs d\u0027entreprises SCRL",
"value": {
"role": "commissaire",
"term": "trois ans",
"start_date": "25/03/2011"
},
"object": null,
"subject": "e7"
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1791,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0459.093.476",
"kind": "company",
"name": "Novartis Pharma S.A.",
"attrs": {
"seat": "Medialaan 40 bte 1, 1800 Vilvoorde"
}
},
{
"id": "e2",
"kbo": "0403.066.474",
"kind": "company",
"name": "GlaxoSmithKline S.A.",
"attrs": {
"seat": "rue du Tilleul 13, 1332 Genval"
}
},
{
"id": "e3",
"kbo": "0415.283.427",
"kind": "company",
"name": "Janssen-Cilag S.A.",
"attrs": {
"seat": "Antwerpseweg 15-17, 2340 Beerse"
}
},
{
"id": "e4",
"kbo": "0403.088.151",
"kind": "company",
"name": "Roche S.A.",
"attrs": {
"seat": "rue Dante 75, 1070 Bruxelles"
}
},
{
"id": "e5",
"kbo": "0464.435.901",
"kind": "company",
"name": "Sanofi-Aventis Belgium S.A.",
"attrs": {
"seat": "Culliganlaan 1C, 1831 Diegem"
}
},
{
"id": "e6",
"kbo": "0439.652.401",
"kind": "company",
"name": "Amgen S.A.",
"attrs": {
"seat": "rue Ariane 5, 1200 Bruxelles"
}
},
{
"id": "e7",
"kbo": "0431.088.289",
"kind": "company",
"name": "BDO R\u00E9viseurs d\u0027entreprises SCRL",
"attrs": {
"rpr": "Bruxelles",
"seat": "Uitbreidingstraat 66/3, 2600 Antwerpen"
}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Leo Neels",
"attrs": {}
},
{
"id": "e9",
"kbo": "0407.622.902",
"kind": "company",
"name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
"attrs": {
"seat": "chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES",
"legal_form": "Association sans But Lucratif",
"short_name": "AGIM"
}
}
]
}09-11-2010 1 director appointed, 2 resigning, 2 reappointed
- Michael Aaron Kelly, Bestuurder
- Thomas Dittrich, Bestuurder
- Giuseppe Trotta, Gedelegeerd bestuurder
- Herman Van den Abeele, Commissaris
- Rolf Karl-Heinz Hoffmann, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Thomas Dittrich",
"address": null,
"birth_date": null
},
"effective_date": "2010-08-30",
"evidence_quote": "De aandeelhouder neemt akte van het ontslag van de heer Thomas Dittrich met ingang op 30 augustus 2010, als bestuurder van de vennootschap."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Michael Aaron Kelly",
"address": null,
"birth_date": null
},
"effective_date": "2010-10-01",
"evidence_quote": "De aandeelhouder beslist om de heer Michael Aaron Kelly, gedomicilieerd te Seestrasse 329, CH 8038 Z\u00FCrich, Zwitserland, als bestuurder van de vennootschap te benoemen, met ingang vanaf 1 oktober 2010."
},
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Herman Van den Abeele",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0439652401",
"name": "Ernst\u0026Young Bedrijfsrevisoren",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2010-06-30",
"evidence_quote": "De aandeelhouder beslist om het mand\u00E1at van de burgerlijke vennootschap onder de vorm van een co\u00F6peratieve vennootschap \u0022Ernst\u0026Young Bedrijfsrevisoren\u0022, met maatschappelijke zetel te 1200 Brussel, M. Thirylaan 204, vertegenwoordigd door Herman Van den Abeele, te verlengen vanaf 30 juni 2010 tot 30 j"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Rolf Karl-Heinz Hoffmann",
"address": null,
"birth_date": null
},
"evidence_quote": "De aandeelhouder beslist om het mandaat van bestuurder van de heer Rolf Karl-Heinz Hoffmann vernieuwen tot 30 juni 2012."
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Giuseppe Trotta",
"address": null,
"birth_date": null
},
"effective_date": "2010-10-01",
"evidence_quote": "Na beraadslaging, beslist de raad van bestuur eenparig om het mandaat van de heer Giuseppe Trotta als gedelegeerd tot het dagelijks bestuur te be\u00EBindigen met ingang op 1 oktober 2010."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0439.652.401",
"name_full": "AMGEN",
"legal_form": "NV"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | AMGEN |